Stock listing

Stuttgart:ZR8 Oncodesign Precision Medicine S.A. Aktie

German listing (Stuttgart) of Oncodesign Precision Medicine S.A. · home listing Euronext:ALOPM

Follow Oncodesign Precision Medicine S.A. into a list and get an email when it puts out news.

Home listing price · EURONEXT:ALOPM

€0.33 EUR +0.02 (+6.5%)

Close on Oct 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, EURONEXT:ALOPM

Past year -26.7% · daily closes, Oct 20, 2025 – Oct 20, 2026, adjusted for splits
Day range
€0.319 – €0.33 EUROct 20, 2026
Volume
1,552 sharesOct 20, 2026
Market cap
€6.29M EURAt the close on Oct 20, 2026 · price × 19.07M shares outstanding
52-week range
€0.20 – €0.92 EURLowest and highest trades, Oct 21, 2025 – Oct 20, 2026
Oncodesign Precision Medicine S.A. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Euronext:ALOPM · Home€0.33 EUR+0.02 (+6.5%)1,552€0.32€0.33€0.319€0.31Close on Oct 20, 2026
Frankfurt:ZR8€0.304 EUR-0.019 (-5.9%)—€0.279€0.304€0.279€0.323Close on Oct 20, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 20, 2026 · EURONEXT:ALOPM · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€0.33+0.02+6.5%€0.32€0.33€0.3191,552
€0.31-0.031-9.1%€0.34€0.348€0.3110,432
€0.341+0.021+6.6%€0.331€0.341€0.333,400
€0.32-0.03-8.6%€0.349€0.349€0.3225,102
€0.35+0.012+3.6%€0.33€0.35€0.3317,900
€0.338-0.011-3.2%€0.322€0.35€0.32233,730
€0.349+0.019+5.8%€0.32€0.35€0.3232,471
€0.33-0.025-7.0%€0.355€0.356€0.3344,535
€0.355+0.022+6.6%€0.36€0.37€0.3431,522
€0.3330.000.0%€0.334€0.35€0.33312,118
€0.333-0.047-12.4%€0.38€0.38€0.33314,966
€0.380.000.0%€0.38€0.385€0.380
€0.38+0.001+0.3%€0.38€0.385€0.387,964
€0.379-0.004-1.0%€0.379€0.38€0.3619,469
€0.383+0.013+3.5%€0.36€0.383€0.3626,405
€0.37+0.024+6.9%€0.36€0.37€0.33616,516
€0.346-0.02-5.5%€0.35€0.35€0.31514,111
€0.366+0.056+18.1%€0.279€0.369€0.279215,448
€0.31+0.054+21.1%€0.271€0.31€0.2645,065
€0.256+0.012+4.9%€0.258€0.31€0.2584,450
€0.244+0.014+6.1%€0.231€0.246€0.2315,593
€0.23-0.016-6.5%€0.245€0.245€0.23845
€0.246+0.009+3.8%€0.237€0.246€0.2321,826
€0.237+0.017+7.7%€0.21€0.237€0.2113,335
€0.22+0.02+10.0%€0.211€0.23€0.2031,615
€0.20-0.015-7.0%€0.216€0.224€0.206,177
€0.215-0.016-6.9%€0.229€0.229€0.2151,801
€0.231-0.008-3.3%€0.238€0.239€0.21549,088
€0.239+0.019+8.6%€0.234€0.257€0.23426,579
€0.22-0.025-10.2%€0.245€0.245€0.2229,941
€0.245+0.005+2.1%€0.23€0.245€0.2249,802
€0.24-0.005-2.0%€0.243€0.244€0.2316,012
€0.245+0.02+8.9%€0.231€0.245€0.239,255
€0.225-0.025-10.0%€0.25€0.25€0.2254,379
€0.25+0.001+0.4%€0.257€0.258€0.258,486
€0.249-0.001-0.4%€0.25€0.258€0.23229,582
€0.25-0.029-10.4%€0.27€0.278€0.2588,910
€0.279-0.002-0.7%€0.28€0.282€0.2660,489
€0.281-0.036-11.4%€0.317€0.317€0.28165,301
€0.317-0.002-0.6%€0.319€0.319€0.3061,429
€0.319-0.003-0.9%€0.319€0.319€0.319201
€0.322+0.001+0.3%€0.31€0.327€0.30217,261
€0.321-0.005-1.5%€0.32€0.326€0.32908
€0.326+0.01+3.2%€0.321€0.326€0.324,730
€0.316+0.002+0.6%€0.316€0.325€0.3151,470
€0.314-0.011-3.4%€0.304€0.327€0.30414,041
€0.325+0.005+1.6%€0.32€0.327€0.323,087
€0.32-0.006-1.8%€0.326€0.327€0.322,083
€0.3260.000.0%€0.327€0.327€0.3261,035
€0.326-0.001-0.3%€0.328€0.328€0.326841
€0.327+0.007+2.2%€0.32€0.328€0.3126,700
€0.32-0.002-0.6%€0.32€0.328€0.323,828
€0.322+0.001+0.3%€0.322€0.328€0.3221,179
€0.321-0.019-5.6%€0.318€0.321€0.3187,015
€0.34+0.029+9.3%€0.313€0.341€0.3137,458
€0.311-0.001-0.3%€0.311€0.311€0.31122
€0.312-0.01-3.1%€0.319€0.32€0.312269
€0.322+0.01+3.2%€0.312€0.322€0.3125,046
€0.312+0.001+0.3%€0.31€0.326€0.31950
€0.311-0.007-2.2%€0.318€0.318€0.312,556
€0.318+0.008+2.6%€0.311€0.32€0.3112,567
€0.31-0.01-3.1%€0.319€0.325€0.3110,797
€0.32-0.004-1.2%€0.325€0.325€0.32595
€0.324+0.001+0.3%€0.32€0.324€0.321,071
€0.323+0.008+2.5%€0.311€0.323€0.311363
€0.315+0.004+1.3%€0.312€0.33€0.3124,709
€0.311-0.005-1.6%€0.33€0.33€0.3112,311
Ticker
Stuttgart:ZR8
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Stuttgart
Currency
EUR

What changed lately

Latest news

OPM Achieved Several Major Scientific and Regulatory Milestones as Part of the LARKIN Program, Supported With Funding By The Michael J. Fox Foundation for Parkinson's Research (MJFF)

Oct 7, 2026

Closed €0.355 (+6.6%) on Oct 8, 2026

OPM Announces Its 2025 Annual Results and Provides an Update on Its Clinical Developments

Apr 30, 2026

Closed €0.458 (+4.1%) on May 4, 2026

Oncodesign Precision Medicine Receives Support from The Michael J. Fox Foundation to Advance Development of LRRK2 Inhibitor OPM-201 for Parkinson’s Disease

Mar 3, 2026

Closed €0.664 (+44.3%) on Mar 4, 2026

Oncodesign Precision Medicine and Ksilink Join Forces to Test the Nanocyclix® Chemical Library in Cell Models Derived From Patients With Serious Central Nervous System Diseases

Jan 8, 2026

Closed €0.84 (+64.7%) on Jan 9, 2026

Oncodesign Precision Medicine and Navigo Proteins Announce the End of Their Collaboration in the Development of Radiotheranostics

Dec 29, 2025

Closed €0.409 (+7.3%) on Dec 30, 2025

OPM Obtains Development Grants From the Bourgogne Franche-Comté Region

Oct 14, 2025

OPM Publishes Its 2025 Half-Yearly Report

Oct 9, 2025

OPM Integrated Into the LRRK2 Investigative Therapeutics Exchange Program From the Michael J. Fox Foundation for Parkinson’s Research

Sep 25, 2025

OPM Announces Its 2025 Half-Year Financial Results and Provides an Update on Its Clinical Developments and Financial Position

Jul 31, 2025

Oncodesign Precision Medicine Announces Equity Financing of up to 5 Million Euros

Apr 17, 2025

All Oncodesign Precision Medicine S.A. news

Decks

Oncodesign Precision Medicine S.A. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
6 in the last 12 months · 20 in all · newest Oct 7, 2026 · oldest 2024
Decks
1 deck · latest Dec 5, 2023

Where Oncodesign Precision Medicine S.A. is listed

ListingExchangeCountryCurrency
Euronext:ALOPM · Home listingEuronextFranceEUR
Lang & Schwarz:A3DVNMLang & SchwarzGermanyEUR
LS Exchange:A3DVNMLS ExchangeGermanyEUR
Frankfurt:ZR8FrankfurtGermanyEUR
Stuttgart:ZR8 · This pageStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Oncodesign Precision Medicine S.A.